Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vision Ease is an ophthalmic lens manufacturer and marketer focused on prescription and sunwear lens products for eye care professionals, retailers, wholesalers, and distributors. The company is best known for polycarbonate, photochromic, polarized, and blue-light-filtering spectacle lenses, and it highlights a long history of lens-material and coating innovation, including early lightweight polycarbonate prescription lenses. Vision Ease operates as a HOYA Vision Care-owned business following HOYA Corporation's 2017 acquisition of Performance Optics, the parent of Vision Ease. Its business is commercial rather than drug-development oriented, with revenue generated from lens products and related customer support for the optical market. For a biotech analyst, this is best categorized as a healthcare-adjacent medical device/vision-care manufacturer rather than a biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vision Ease.